Sort by
Medicine and Dentistry
Meta-Analysis
100%
Pooled Analysis
100%
Radiation Therapy
77%
Progression Free Survival
75%
Malignant Neoplasm
66%
Arm
65%
Prevalence
60%
Overall Survival
52%
Diseases
47%
Diabetes
46%
Neoplasm
44%
Cancer Treatment
44%
Phase II Trials
37%
Prostate Cancer
33%
Quality of Life
33%
Hodgkin's Lymphoma
33%
Pulse Wave Velocity
33%
Cross Sectional Study
33%
Arterial Stiffness
33%
Dietary Intake
33%
Schistosoma Mansoni
33%
Systematic Review
33%
Colorectal Liver Metastasis
33%
Soft Tissue Sarcoma
33%
Clinical Trial Design
33%
Osteosarcoma
33%
Distant Metastasis
33%
Adriamycin Bleomycin Vinblastine Dacarbazine
33%
Body Mass Index
33%
Abdominal Obesity
33%
Drug Use
33%
Polyethylene Terephthalate
33%
Thymus Cancer
33%
Thymic Carcinoma
33%
Cancer Registry
33%
Anticonvulsant
33%
Psychoactive Drug
33%
Congenital Malformation
33%
Survival Rate
33%
Cohort Analysis
33%
Hospital Mortality
33%
Nivolumab
33%
Molecular Diagnostics
33%
Molecularly Targeted Therapy
33%
Retrospective Study
33%
Hypoglycemia
33%
Insulin Dependent Diabetes Mellitus
33%
Rifampicin
33%
Randomized Controlled Trial
33%
Diagnostic Test
33%
Precision Oncology
33%
Prospective Study
33%
Proportional Hazards Model
27%
Postoperative Complication
26%
Hazard Ratio
25%
Targeted Therapy
23%
Breast Cancer
22%
Distant Metastasis Free Survival
20%
Edema
20%
Neutropenia
19%
Univariate Analysis
17%
Recurrent Disease
16%
Physical Activity
16%
Schistosomiasis
16%
Sodium Valproate
16%
Ipilimumab
16%
Adverse Event
16%
Next Generation Sequencing
16%
Molecular Profiling
16%
Advanced Cancer
16%
Supportive Care
16%
Health Care Cost
16%
Diagnostic Accuracy
15%
Clinical Trial
15%
Hepatectomy
13%
Liver Surgery
13%
Health Outcomes
12%
False Negative Result
12%
Hemispheric Dominance
11%
Quadrantectomy
11%
Kaplan Meier Method
11%
Socioeconomic Status
11%
Patient Population
11%
Gene Linkage
11%
Adjuvant Therapy
11%
Antidepressant
11%
Sepsis
11%
Anthropometry
11%
Positron Emission Tomography
8%
Patient Selection
8%
False Positive Result
8%
Antibiotics
8%
Myocarditis
8%
Study Participant
8%
Dietary Antioxidant
8%
Medical Oncology
8%
Mixed Model
8%
Infection
8%
Cancer
8%
Enzyme Linked Immunosorbent Assay
8%
Keyphrases
PFS2
33%
Rifampicin Resistance
33%
Direct Examination
33%
Stepped-wedge Trial
33%
Latent Class Model
33%
Shorter Regimen
33%
Microfilaraemia
33%
Thick Blood Smear
33%
Arm Circumference
33%
Immediate Release Tablets
33%
Sustained Release Pellets
33%
Oral Sustained Release
33%
Multiple Indicator Cluster Survey
33%
Severe Malnutrition
33%
Intra-abdominal Hypertension
33%
Acute Hospital
33%
Eastern Democratic Republic of Congo
33%
Hospital Mortality
33%
Thymic Carcinoma
33%
Type B3 Thymoma
33%
Fear of Sleep
33%
Test Comparison
33%
Limited-stage
33%
Relapse Pattern
33%
Schistosoma Haematobium
33%
Localized Prostate Cancer
33%
Failure Event
33%
High-dose Radiotherapy
33%
Treatment Intensification
33%
Radiotherapy Dose
33%
Linkage Method
33%
Database Linkage
33%
Linked Database
33%
Medication Exposure
33%
Drug Use in Pregnancy
33%
Comparative Risk
33%
Human Respiratory Viruses
33%
Synovial Sarcoma
33%
Liposarcoma
33%
Uganda
33%
Short-term Outcomes
33%
Resource-limited Settings
33%
Children with Cancer
33%
Surveillance Indicators
33%
Flux Monitoring
33%
Upper Arm Circumference
33%
One-stage Resection
26%
Radiotherapy Dose Escalation
26%
Treatment Coverage
25%
Hepatitis B Antigens
22%
Combination Vaccine
22%
MUACZ
22%
Wastewater Surveillance
22%
ALPPS
20%
Optimal Treatment
20%
5-Flucytosine
16%
Plasma Exposure
16%
Viral RNA Levels
16%
Environmental Surveillance
16%
Diagnostic Techniques
16%
Reagent Strips
16%
Neutropenia
16%
Sepsis
16%
Working Diagnosis
16%
Liver Surgery
13%
Relative Benefit
13%
Matched Therapy
11%
Actionable mutations
11%
Best Supportive Care
11%
Ethnolinguistic Groups
11%
Infectious Disease Surveillance
11%
Research Building
11%
Expanded Access
11%
Regional Economics
11%
Hmong-Mien
11%
Minority Groups
11%
Uganda Cancer Institute
11%
Diagnostic Accuracy
11%
Edema Resolution
11%
Nutritional Rehabilitation
11%
Water System
11%
Particle Dynamics
11%
Laboratory-confirmed Influenza
11%
Concentration of Measure
11%
Non-invasive Approach
11%
Hydrological Monitoring
11%
Raw Urban Wastewater
11%
Wastewater Detection
11%
Influenza Seasonality
11%
Therapeutic Boundaries
8%
Steady-state Plasmas
8%
Phase I Trial
8%
Concentrations-time Profiles
8%
Opportunistic Fungal Infections
8%
Immediate-release Formulation
8%
Cryptococcal Meningitis
8%
Pellet Formulation
8%
Maximum Time
8%
Recreational Water
8%
Wastewater-based Epidemiology
8%
Pharmacology, Toxicology and Pharmaceutical Science
Edema
86%
Malignant Neoplasm
77%
Prevalence
73%
Sustained Release
66%
Flucytosine
66%
Bioavailability
66%
Progression Free Survival
41%
Phase II Trials
37%
Tablet
36%
Overall Survival
36%
Prostate Cancer
33%
Hepatitis B
33%
Cohort Study
33%
Nivolumab
33%
Stillbirth
33%
Normal Human
33%
Hospital Mortality
33%
Synovial Sarcoma
33%
Cancer Registry
33%
Liposarcoma
33%
Cryptococcal Meningitis
33%
Microfilariasis
33%
Survival Rate
33%
Loiasis
33%
Carcinoma
33%
Osteosarcoma
33%
Clinical Trial Design
33%
Distant Metastasis
33%
Soft Tissue Sarcoma
33%
Prospective Study
33%
Long Term Survival
33%
Breast Cancer
22%
Distant Metastasis Free Survival
20%
Pharmacokinetics
20%
Adverse Event
20%
Neutropenia
19%
Ipilimumab
16%
Chemotherapy
16%
Diseases
15%
Meningoencephalitis
13%
Combination Vaccine
13%
Hepatitis B Antigen
13%
Neoplasm
11%
Sepsis
11%
Mycosis
10%
HIV
10%
Recurrent Disease
8%
Thorax Tumor
8%
Hypertransaminasemia
8%
Myocarditis
8%
Autoimmune Disease
8%
Monotherapy
8%
Kwashiorkor
8%
Physiologically Based Pharmacokinetic Modelling
6%
Pharmacokinetic Parameter
6%
Eosinophilia
6%
Bioequivalence
6%
Phase I Trials
6%
Tropical Disease
6%
Infection
6%
Low-Dose Radiotherapy
6%
Antipsychotic Drug
5%